North Star Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.06M | Buy |
6,883
+864
| +14% | +$385K | 0.13% | 116 |
|
|
2025
Q1 | $2.92M | Buy |
6,019
+196
| +3% | +$95K | 0.13% | 115 |
|
|
2024
Q4 | $2.34M | Buy |
5,823
+100
| +2% | +$40.3K | 0.1% | 127 |
|
|
2024
Q3 | $2.66M | Hold |
5,723
| – | – | 0.12% | 118 |
|
|
2024
Q2 | $2.68M | Hold |
5,723
| – | – | 0.13% | 118 |
|
|
2024
Q1 | $2.39M | Sell |
5,723
-2
| -0% | -$836 | 0.11% | 125 |
|
|
2023
Q4 | $2.33M | Buy |
5,725
+5
| +0.1% | +$2.03K | 0.12% | 122 |
|
|
2023
Q3 | $1.99M | Hold |
5,720
| – | – | 0.11% | 131 |
|
|
2023
Q2 | $2.01M | Buy |
5,720
+5
| +0.1% | +$1.76K | 0.11% | 130 |
|
|
2023
Q1 | $1.8M | Sell |
5,715
-35
| -0.6% | -$11K | 0.11% | 131 |
|
|
2022
Q4 | $1.66M | Hold |
5,750
| – | – | 0.1% | 127 |
|
|
2022
Q3 | $1.67M | Sell |
5,750
-25
| -0.4% | -$7.24K | 0.11% | 126 |
|
|
2022
Q2 | $1.63M | Hold |
5,775
| – | – | 0.11% | 129 |
|
|
2022
Q1 | $1.51M | Hold |
5,775
| – | – | 0.08% | 145 |
|
|
2021
Q4 | $1.27M | Hold |
5,775
| – | – | 0.06% | 152 |
|
|
2021
Q3 | $1.05M | Buy |
5,775
+2,100
| +57% | +$381K | 0.06% | 156 |
|
|
2021
Q2 | $741K | Buy |
3,675
+25
| +0.7% | +$5.04K | 0.04% | 178 |
|
|
2021
Q1 | $784K | Hold |
3,650
| – | – | 0.05% | 170 |
|
|
2020
Q4 | $863K | Hold |
3,650
| – | – | 0.05% | 155 |
|
|
2020
Q3 | $993K | Hold |
3,650
| – | – | 0.07% | 132 |
|
|
2020
Q2 | $1.06M | Hold |
3,650
| – | – | 0.08% | 127 |
|
|
2020
Q1 | $869K | Sell |
3,650
-300
| -8% | -$71.4K | 0.08% | 127 |
|
|
2019
Q4 | $865K | Hold |
3,950
| – | – | 0.06% | 163 |
|
|
2019
Q3 | $669K | Hold |
3,950
| – | – | 0.05% | 176 |
|
|
2019
Q2 | $724K | Hold |
3,950
| – | – | 0.06% | 170 |
|
|
2019
Q1 | $727K | Hold |
3,950
| – | – | 0.06% | 163 |
|
|
2018
Q4 | $655K | Hold |
3,950
| – | – | 0.06% | 167 |
|
|
2018
Q3 | $761K | Hold |
3,950
| – | – | 0.06% | 171 |
|
|
2018
Q2 | $671K | Hold |
3,950
| – | – | 0.06% | 177 |
|
|
2018
Q1 | $644K | Hold |
3,950
| – | – | 0.06% | 179 |
|
|
2017
Q4 | $592K | Buy |
+3,950
| New | +$592K | 0.05% | 190 |
|